Posted inClinical Updates Hematology-Oncology
Aligning Clinical Trial Reporting in Myelodysplastic Syndromes: Key Recommendations from the International Consortium for MDS
The International Consortium for MDS issues a consensus to standardize clinical trial reporting in MDS—defining required baseline elements, harmonized endpoints (including transfusion independence and overall response), safety reporting, and templates to improve interpretability and regulatory decision-making.
